| 产品编号 | bsk11002 |
| 英文名称 | Human IL-2 ELISA Kit |
| 中文名称 | 人白细胞介素2酶联免疫试剂盒 |
| 别 名 | IL2, IL-2, TCGF, lymphokine, interleukin 2 |
 |
Specific References (2) | bsk11002 has been referenced in 2 publications.
[IF=17.521] Lizhen He. et al. Metabolic Reprogramming of NK Cells by Black Phosphorus Quantum Dots Potentiates Cancer Immunotherapy. Advanced Science. 2023 Jan;:2202519 ELISA ; Human.
[IF=10.273] Lai H et al. Selenium-containing ruthenium complex synergizes with natural killer cells to enhance immunotherapy against prostate cancer via activating TRAIL/FasL signaling. Biomaterials. 2019 Jul 24;219:119377. ELISA ; Human.
|
| 种 属 | Human |
| 线性范围 | 7.81 - 500 pg/mL |
| 应用范围 | S/P/CC |
| 检测限 | 4 pg/mL |
| 适用样品基质 | cell culture supernates, serum, and plasma. |
| 保存条件 | Store at 4°C for 6 months, at -20°C for 12 months. Avoid multiple freeze-thaw cycles (Shipped with wet ice.). |
| 注意事项 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 产品介绍 |
Interleukin 2 (IL-2) is a pleiotropic cytokine produced primarily by mitogen- or antigen-activated T lymphocytes. Human IL-2 (also known as T-cell growth factor) is produced by T-cells in response to antigenic or mitogenic stimulation. IL-2 is a potent lymphoid cell growth factor which exerts its biological activity primarily on T cells promoting proliferation and maturation.IL-2 has been found to stimulate growth and differentiation of B cells, NK cells, LAK cells, monocytes, and oligodendocytes. IL-2 is involved in treatment of cancers such as melanoma and renal cell cancer. It plays a key role in promoting the clonal expansion of antigen-specific T cells. In addition, IL-2 has also been shown to mediate multiple immune responses on a variety of cell types.
白介素-2(Interleukin-2,IL-2)是辅助型T淋巴细胞(TH)活化产生的细胞因子[1-2]。IL-2具有双重调控免疫应变的能力,可有效诱导细胞免疫和体液免疫应答。 白介素（IL-2)的主要生理作用是刺激和维持T细胞的分化增殖。IL-2有关肿瘤的生物学活性包括：1.刺激自然杀伤(NK)细胞的增殖和活化，并增强其活性。2.诱导细胞毒性淋巴细胞，增强其溶细胞活性。3.诱导淋巴因子活化杀伤(LAK)细胞。LAK细胞具有广谱的抗肿瘤活性，可以溶解多种肿瘤细胞。IL-2不仅是产生LAK细胞的必需淋巴因子，而且在它的存在下还能维持LAK细胞的增殖和长期生长，因此，在临床抗肿瘤治疗时往往把IL-2和LAK细胞同时给予，这就是恶性肿瘤的过继免疫性治疗(adoptiveimmunetherapy，AIT)。4.刺激肿瘤浸润淋巴细胞(TIL)的增生并增强其活性。动物实验证明，TIL较LAK细胞的抗肿瘤活性高50～100倍。5.不仅能促进T细胞增殖，且对细胞有促增殖和促分化作用。在肿瘤治疗的动物模型中已证明，当T细胞中介抗瘤反应强烈时，很低量的IL-2已足以激化抗瘤作用；但当T细胞中介的抗瘤反应很弱时，则需要很高剂量的IL-2。低剂量可以显著地刺激T细胞，而激活NK及LAK细胞则要求很大剂量。因IL-2不能直接抗癌，用药目的是最大限度地兴奋免疫机制，以加强抗癌作用。以前常用的IL-2和LAK细胞联合应用治疗恶性肿瘤，现已不再推荐，而代之以IL-2与肿瘤浸润淋巴细胞(TIL)联合疗法。6.rhIL-11为177个氨基酸组成的活性蛋白质。其编码基因位于19号染色体长臂13区。作用于巨核细胞系较晚期阶段的巨核细胞水平，促进巨核细胞的增殖及成熟，并促进血小板的产生。IL-11虽无巨核细胞集落刺激因子(Meg-CSF)的活性，但有巨核细胞增殖因子的活性，与GM-CSF及IL-3协同作用，可使CFU-MegDNA量增多。 |
| 1、抗体溶解方法 | |
| 2、抗体修复方式 | |
| 3、常用试剂的配制 | |
| 4、免疫组化操作步骤 | |
| 5、免疫组化问题解答 | |
| 6、Western Blotting 操作步骤 | |
| 7、Western Blotting 问题解答 | |
| 8、关于肽链的设计 | |
| 9、多肽的溶解与保存 | |
| 10、酶标抗体效价测定程序 | |
